Skip to main content
Signal8

ADELMAN BURT A

SEC insider (Form 3/4/5 filer). CIK 0001226283. Director at Verve Therapeutics, Inc. (VERV). 5 reported Form 4/5 transactions since Sep 2024; latest on Jul 25, 2025. Located in BOSTON, MA.

Companies ADELMAN BURT A has filed insider reports for

  • Verve Therapeutics, Inc. (VERV): Director
ADELMAN BURT A profile photo

ADELMAN BURT A

CIK: 0001226283

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (80.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Verve Therapeutics, Inc. logo
VERV

Verve Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Tender Offer
    Indirect
    428.3K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Stock Option (right to buy)

    Direct
    136.1K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Stock Option (right to buy)

    Direct
    42.2K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Stock Option (right to buy)

    Direct
    43.2K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jun 5, 2025
    Award

    Stock Option (right to buy)

    Direct
    42.2K shares-

1-5 of 5